QID 92077

Date Published: 2023-11-15

QID 92077: Microsoft Visual Studio Security Updates for November 2023

Microsoft has released November 2023 security updates for Visual Studio to fix multiple security vulnerabilities.

Affected Software:
Microsoft Visual Studio 2022 version 17.7
Microsoft Visual Studio 2022 version 17.6
Microsoft Visual Studio 2022 version 17.4
Microsoft Visual Studio 2022 version 17.2
Microsoft Visual Studio 2019 version 16.11 (includes 16.0 - 16.10)

QID Detection Logic: Authenticated : Windows
This QID detects vulnerable versions of Microsoft Visual Studio by checking the registry key "HKLM\SOFTWARE\Microsoft" and file "devenv.exe" to check the version of the Visual Studio.

Vulnerable versions of Microsoft Visual Studio are prone to Denial of Service, Security Feature Bypass, and Elevation of Privilege vulnerability.

  • CVSS V3 rated as High - 6.2 severity.
  • CVSS V2 rated as Medium - 4.9 severity.
    • Solution
    Customers are advised to refer to CVE-2023-36042, CVE-2023-36558, CVE-2023-36049, CVE-2023-36038 for more information on the vulnerability and it's patch.
    Vendor References

    CVEs related to QID 92077

    CVE-2023-36042 | CVE-2023-36558 | CVE-2023-36049 | CVE-2023-36038 |
    Software Advisories
    Advisory ID Software Component Link
    CVE-2023-36038 URL Logo msrc.microsoft.com/update-guide/vulnerability/CVE-2023-36038
    CVE-2023-36042 URL Logo msrc.microsoft.com/update-guide/vulnerability/CVE-2023-36042
    CVE-2023-36049 URL Logo msrc.microsoft.com/update-guide/vulnerability/CVE-2023-36049
    CVE-2023-36558 URL Logo msrc.microsoft.com/update-guide/vulnerability/CVE-2023-36558
    By selecting these links, you may be leaving CVEreport webspace. We have provided these links to other websites because they may have information that would be of interest to you. No inferences should be drawn on account of other sites being referenced, or not, from this page. There may be other websites that are more appropriate for your purpose. CVEreport does not necessarily endorse the views expressed, or concur with the facts presented on these sites. Further, CVEreport does not endorse any commercial products that may be mentioned on these sites. Please address comments about any linked pages to [email protected].